Literature DB >> 17277663

Laparoscopic pyelolithotomy with intraperitoneal ultrasonic lithotripsy: report of a novel minimally invasive technique for intracorporeal stone ablation.

Sean Collins1, Franzo Marruffo, Evren Durak, Greg Hruby, Ari Bergman, Mantu Gupta, Jaime Landman.   

Abstract

We present the case of a 71-year-old Hispanic woman with a 4-cm stone in the renal pelvis of a kidney with thin parenchyma. Retrograde pyelography revealed a normal ureter and normal ureteropelvic junction. A ureteral stent was placed. Six weeks after the stent was placed, a differential renal scan revealed 18% function of the involved kidney. A percutaneous nephrolithotomy was not performed because of the thin parenchyma and intrarenal anatomy, which would have complicated access. The patient underwent an uncomplicated laparoscopic pyelolithotomy. The stone was placed into an Endocatch entrapment sack. The open end of the Endocatch sack was brought through a trocar site, and a nephroscope and ultrasonic lithotripter were deployed. The stone was fragmented and aspirated in the standard manner, thereby avoiding the need to extend the 12-mm trocar incision for stone extraction. The stone fragmentation and extraction time was 14 minutes. The patient was stone-free and discharged home in the morning of the first postoperative day without complications.

Entities:  

Mesh:

Year:  2006        PMID: 17277663     DOI: 10.1097/01.sle.0000213725.34591.78

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

Review 1.  Laparoscopic urinary stone surgery: an updated evidence-based review.

Authors:  Andreas Skolarikos; Athanasios G Papatsoris; Stefanos Albanis; Dean Assimos
Journal:  Urol Res       Date:  2010-04-16

2.  [Combined flexible and semirigid ureteroscopy with laser lithotripsy. Alternative to percutaneous nephrolithotomy of complex EWSL refractory nephrolithiasis].

Authors:  A K Ebert; W Schafhauser
Journal:  Urologe A       Date:  2008-08       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.